# McKESSON CORPORATION (MCK) FY2026 Q1 P&L / Income Statement

- Company: McKESSON CORPORATION (MCK)
- Period: 2025-04-01 to 2025-06-30
- Filing: Q1 FY2026 10-Q, filed 2025-08-06, accession number 0000927653-25-000107
- Page: https://plicit.ai/financials/mck/fy2026-q1-income-statement
- Chart image: https://plicit.ai/charts/mck-fy2026-q1-income-statement-sankey.png

## Chart details: Revenue by Business Segment

Income statement for 2025-04-01 through 2025-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenues**: 97,827,000,000 US dollars
- **Cost of sales**: 94,548,000,000 US dollars
- **Gross profit**: 3,279,000,000 US dollars
- **Total operating expenses**: 2,243,000,000 US dollars
- **Operating income**: 1,036,000,000 US dollars
- **Other income (expense), net (calculated)**: 15,000,000 US dollars
- **Income before income taxes**: 1,051,000,000 US dollars
- **Income tax expense**: 220,000,000 US dollars
- **Net income**: 831,000,000 US dollars
- **U.S. Pharmaceutical**: 89,954,000,000 US dollars
- **Prescription Technology Solutions**: 1,434,000,000 US dollars
- **Medical-Surgical Solutions**: 2,701,000,000 US dollars
- **International**: 3,738,000,000 US dollars
- **Selling, distribution, general, and administrative expenses**: 2,196,000,000 US dollars
- **Claims and litigation charges, net**: 0 US dollars
- **Restructuring, impairment, and related charges, net**: 47,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to McKESSON CORPORATION: $784.00 M; to noncontrolling interests: $47.00 M.